相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hypoxia inducible factor-1 upregulates adiponectin in diabetic mouse hearts and attenuates post-ischemic injury
Ramesh Natarajan et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Selective modulation of promoter recruitment and transcriptional activity of PPARγ
Dorothy D. Sears et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
A. Michael Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse
Patrick Yue et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association functional class I or II heart failure
Henry J. Dargie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Pioglitazone induces de novo ceramide synthesis in the rat heart
Marcin Baranowski et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II-anglotensin type 1 receptor system
Yoshitaka Iwanaga et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone
Hisashi Makino et al.
DIABETES (2006)
Differences in hepatotoxicity and gene expression profiles by anti-diabetic PPARγ agonists on rat primary hepatocytes and human HepG2 cells
Lei Guo et al.
MOLECULAR DIVERSITY (2006)
Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin
M. Heishi et al.
DIABETOLOGIA (2006)
Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity
J Buchanan et al.
ENDOCRINOLOGY (2005)
Adiponectin is synthesized and secreted by human and murine cardiomyocytes
R Piñeiro et al.
FEBS LETTERS (2005)
Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-γ both induce cardiac hypertrophy in mice
SZ Duan et al.
CIRCULATION RESEARCH (2005)
The role of the adipocyte hormone adiponectin in cardiovascular disease
C Hug et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Treatment of type 2 diabetic db/db mice with a novel PPARγ agonist improves cardiac metabolism but not contractile function
AN Carley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Positive selection on MMP3 regulation has shaped heart disease risk
MV Rockman et al.
CURRENT BIOLOGY (2004)
Impact of PPARγ overexpression and activation on pancreatic islet gene expression profile analyzed with oligonucleotide microarrays
LE Parton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Gene expression profiling of potential PPARγ target genes in mouse aorta
HL Keen et al.
PHYSIOLOGICAL GENOMICS (2004)
Thiazolidinedione use, fluid retention, and congestive heart failure
RW Nesto et al.
DIABETES CARE (2004)
Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction
MM Chen et al.
CIRCULATION (2003)
Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction
S Beyzade et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Peroxisome proliferator-activated receptor (PPAR) α and PPARβ/δ, but not PPARγ, modulate the expression of genes involved in cardiac lipid metabolism
AJ Gilde et al.
CIRCULATION RESEARCH (2003)
Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice
E Aasum et al.
DIABETES (2003)
Lipoapoptosis: its mechanism and its diseases
RH Unger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Echocardiographic assessment of cardiac function in diabetic db/db and transgenic db/db-hGLUT4 mice
LM Semeniuk et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the Zucker fatty rat heart
RJ Sidell et al.
DIABETES (2002)
Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation
T Albrektsen et al.
DIABETES (2002)
Sphingolipid mediators in cardiovascular cell biology and pathology
T Levade et al.
CIRCULATION RESEARCH (2001)
Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes
Y Shimoni
JOURNAL OF PHYSIOLOGY-LONDON (2001)
PPARγ:: a nuclear regulator of metabolism, differentiation, and cell growth
ED Rosen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists
JM Olefsky
JOURNAL OF CLINICAL INVESTIGATION (2000)
Peroxisome proliferator-activated receptors in the cardiovascular system
D Bishop-Bailey
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Lipotoxic heart disease in obese rats: Implications for human obesity
YT Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
